These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21062299)

  • 21. New results from the use of bisphosphonates in cancer patients.
    Coleman R; Gnant M
    Curr Opin Support Palliat Care; 2009 Sep; 3(3):213-8. PubMed ID: 19561507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bisphosphonates for cancer patients: why, how, and when?
    Body JJ; Mancini I
    Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Approaches to managing bone metastases from breast cancer: the role of bisphosphonates.
    Mystakidou K; Katsouda E; Stathopoulou E; Vlahos L
    Cancer Treat Rev; 2005 Jun; 31(4):303-11. PubMed ID: 16039956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumor effects of bisphosphonates: promising preclinical evidence.
    Guise TA
    Cancer Treat Rev; 2008; 34 Suppl 1():S19-24. PubMed ID: 18486348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of bisphosphonates in prevention and treatment of bone metastases from breast cancer.
    Paterson AH; Kanis JA; Powles TJ; McCloskey E; Hanson J; Ashley S
    Can J Oncol; 1995 Dec; 5 Suppl 1():54-7. PubMed ID: 8853526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mechanism and treatment of cancer metastasis to bone].
    Yoneda T
    Clin Calcium; 2005 Jul; 15(7):29-37. PubMed ID: 15995293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bisphosphonates and bone metastases: current status and future directions.
    Krempien R; Niethammer A; Harms W; Debus J
    Expert Rev Anticancer Ther; 2005 Apr; 5(2):295-305. PubMed ID: 15877526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The potential role of bisphosphonates in prostate cancer.
    Oades GM; Coxon J; Colston KW
    Prostate Cancer Prostatic Dis; 2002; 5(4):264-72. PubMed ID: 12627210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On the horizon: can bisphosphonates prevent bone metastases?
    Coleman R
    Breast; 2007 Dec; 16 Suppl 3():S21-7. PubMed ID: 17988867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are bisphosphonates the suitable anticancer drugs for the elderly?
    Santini D; Fratto ME; Galluzzo S; Vincenzi B; Tonini G
    Crit Rev Oncol Hematol; 2009 Jan; 69(1):83-94. PubMed ID: 18692400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aredia: the once-monthly infusion for the treatment of bone metastases.
    Lipton A
    Curr Opin Oncol; 1998 Aug; 10 Suppl 1():S1-5. PubMed ID: 9801852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-tumour activity of zoledronic acid.
    Clézardin P
    Cancer Treat Rev; 2005; 31 Suppl 3():1-8. PubMed ID: 16225995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diphosphonates--pharmacology and clinical use].
    Aaseth J; Syversen U; Førre O
    Tidsskr Nor Laegeforen; 1998 Mar; 118(7):1064-6. PubMed ID: 9531831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bisphosphonates induce apoptosis of stromal tumor cells in giant cell tumor of bone.
    Cheng YY; Huang L; Lee KM; Xu JK; Zheng MH; Kumta SM
    Calcif Tissue Int; 2004 Jul; 75(1):71-7. PubMed ID: 15037971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bisphosphonate actions on cancer.
    Yoneda T; Hashimoto N; Hiraga T
    Calcif Tissue Int; 2003 Oct; 73(4):315-8. PubMed ID: 12874704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bisphosphonates' antitumor activity: an unravelled side of a multifaceted drug class.
    Clézardin P
    Bone; 2011 Jan; 48(1):71-9. PubMed ID: 20655399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Could targeting bone delay cancer progression? Potential mechanisms of action of bisphosphonates.
    Aft R; Perez JR; Raje N; Hirsh V; Saad F
    Crit Rev Oncol Hematol; 2012 May; 82(2):233-48. PubMed ID: 21683613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Bisphosphonates: indications in bone diseases other than osteoporosis].
    Abdelmoula LC; Ben M'barek R; Ben Hadj Yahia C; Tekaya R; Testouri N; Chaabouni L; Zouari R
    Tunis Med; 2011 Jun; 89(6):511-6. PubMed ID: 21681711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of bisphosphonates in the treatment of painful metastatic bone disease: a review of phase III trials.
    Fulfaro F; Casuccio A; Ticozzi C; Ripamonti C
    Pain; 1998 Dec; 78(3):157-169. PubMed ID: 9870569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bisphosphonate-Functionalized Imaging Agents, Anti-Tumor Agents and Nanocarriers for Treatment of Bone Cancer.
    Nadar RA; Margiotta N; Iafisco M; van den Beucken JJJP; Boerman OC; Leeuwenburgh SCG
    Adv Healthc Mater; 2017 Apr; 6(8):. PubMed ID: 28207199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.